Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis.

Lee, Chern-Horng; Hsu, Chiu-Yi; Yen, Tzung-Hai; Wu, Tsung-Han; Yu, Ming-Chin; Hsieh, Sen-Yung

Lee, Chern-Horng; Hsu, Chiu-Yi; Yen, Tzung-Hai; Wu, Tsung-Han; Yu, Ming-Chin; Hsieh, Sen-Yung.

Afiliación

Lee CH; Division of General Medicine and Geriatrics, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 333, Taiwan.
Hsu CY; Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Linkou, Taoyuan 333, Taiwan.
Yen TH; Department of Nephrology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 333, Taiwan.
Wu TH; Department of General Surgery, Chang Gung Memorial Hospital, Linkou, Taoyuan 333, Taiwan.
Yu MC; Department of General Surgery, Chang Gung Memorial Hospital, Linkou, Taoyuan 333, Taiwan.
Hsieh SY; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 333, Taiwan.

Cancers (Basel) ; 15(11)2023 May 27.

Article en En | MEDLINE | ID: mdl-37296908

Palabras clave

antiplatelet agents; aspirin; chemoprevention; cirrhosis; hepatocellular carcinoma; liver cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cirrhosis / 6_liver_cancer Tipo de estudio: Incidence_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google